Islatravir and Methadone Pharmacokinetics (MK-8591-029)

Clinical trial NCT04568603 · COMPLETED

Trial details

NCT number: NCT04568603
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

HIV-1 Infection

Start date: 2020-10-16
Primary completion: 2021-07-09
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.